Epify is a Maastricht-based developer of epigenetic biomarkers for the detection of gene activity and cancer predisposition.
$500.0k
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Name | Phone | Social networks | |
---|---|---|---|
MA*** VA* EN****** | - | - | - |
WI* VA* CR******* | - | - | - |